Structural requirements of acetylcholinesterase reactivators

. 2006 Mar ; 6 (3) : 269-77.

Jazyk angličtina Země Nizozemsko Médium print

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid16515465

Nerve agents (sarin, soman, cyclosarin, tabun and VX agent) and pesticides (paraoxon, chlorpyrifos, TEPP) represent extremely toxic group of organophosphorus compounds (OPCs). These compounds inhibit enzyme acetylcholinesterase (AChE, EC 3.1.1.7) via its phosphorylation or phosphonylation at the serine hydroxy group in its active site. Afterwards, AChE is not able to serve its physiological function and intoxicated organism is died due to overstimulation of cholinergic nervous system. The current standard treatment of poisoning with highly toxic OPCs usually consists of the combined administration of anticholinergic drugs (preferably atropine) and AChE reactivators (called "oximes"). Anticholinergic drugs block effects of accumulated neurotransmitter acetylcholine at nicotinic and muscarinic receptor sites, while oximes reactivate AChE inhibited by OPCs. Unfortunately, none from the currently used oximes is sufficiently effective against all known nerve agents and pesticides. Therefore, to find new oximes able to sufficiently reactivate inhibited AChE (regardless of the type of OPCs) is still very important task for medicinal chemistry with the aim to improve the efficacy of antidotal treatment of the acute poisonings mentioned. In this paper, the relationship between chemical structure of AChE reactivators and their ability to reactivate AChE inhibited by several nerve agents and pesticides is summarized. It is shown that there are several structural fragments possibly involving in the structure of proposed AChE reactivators. Finally, an attempt of a future course of new AChE reactivators development is discussed.

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

In Vitro Evaluation of Oxidative Stress Induced by Oxime Reactivators of Acetylcholinesterase in HepG2 Cells

. 2023 Dec 18 ; 36 (12) : 1912-1920. [epub] 20231111

Strategies for enhanced bioavailability of oxime reactivators in the central nervous system

. 2023 Nov ; 97 (11) : 2839-2860. [epub] 20230829

Trends in the Recent Patent Literature on Cholinesterase Reactivators (2016-2019)

. 2020 Mar 12 ; 10 (3) : . [epub] 20200312

Molecular Modeling Study of Uncharged Oximes Compared to HI-6 and 2-PAM Inside Human AChE Sarin and VX Conjugates

. 2020 Mar 10 ; 5 (9) : 4490-4500. [epub] 20200226

Acetylcholinesterase: The "Hub" for Neurodegenerative Diseases and Chemical Weapons Convention

. 2020 Mar 07 ; 10 (3) : . [epub] 20200307

In Vitro Evaluation of Neutral Aryloximes as Reactivators for Electrophorus eel Acetylcholinesterase Inhibited by Paraoxon

. 2019 Oct 08 ; 9 (10) : . [epub] 20191008

Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking Study

. 2018 Sep 07 ; 23 (9) : . [epub] 20180907

Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon

. 2018 May 07 ; 23 (5) : . [epub] 20180507

A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase

. 2018 Feb 21 ; 19 (1) : 8. [epub] 20180221

The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203

. 2017 Jul 11 ; 22 (7) : . [epub] 20170711

Computational enzymology for degradation of chemical warfare agents: promising technologies for remediation processes

. 2017 ; 3 (1) : 108-135. [epub] 20170314

A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication

. 2016 Jul 01 ; 5 (4) : 1012-1016. [epub] 20160525

Effect of seven newly synthesized and currently available oxime cholinesterase reactivators on cyclosarin-intoxicated rats

. 2009 Jul 07 ; 10 (7) : 3065-3075. [epub] 20090707

A comparison of the neuroprotective efficacy of newly developed oximes (K117, K127) and currently available oxime (obidoxime) in tabun-poisoned rats

. 2009 Mar ; 19 (3) : 232-8.

Effect of several new and currently available oxime cholinesterase reactivators on tabun-intoxicated rats

. 2008 Nov ; 9 (11) : 2243-2252. [epub] 20081114

Amperometric Biosensors for Real Time Assays of Organophosphates

. 2008 Sep 01 ; 8 (9) : 5303-5312. [epub] 20080901

The present approaches to the development of prophylactic and therapeutic antidotes against nerve agents

. 2008 Jun ; 1 (1) : 18-21.

Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide--a new nerve agent reactivator

. 2007 Aug 20 ; 12 (8) : 1964-72. [epub] 20070820

Two step synthesis of a non-symmetric acetylcholinesterase reactivator

. 2007 Aug 07 ; 12 (8) : 1755-61. [epub] 20070807

In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases

. 2007 Feb ; 11 (2) : 101-6.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...